MAGE - 3 (271 - 279)

Description:

This is a HLA-A*0201–restricted peptide derived from melanoma antigens encoded by MAGE-3.The MAGE-3 gene is a member of a multigene family that is selectively expressed by different human tumor types

Sequence:

FLWGPRALV

General

References

Comments (0)

Name	MAGE - 3 (271 - 279)
Category	Cancer Research Peptides
One Letter Code	FLWGPRALV
Three Letter Code	{Phe}{Leu}{Trp}{Gly}{Pro}{Arg}{Ala}{Leu}{Val}
Molecular Weight	1058.300
Application	Antigen-presenting CellsCancer Research

Paczesny, Sophie, et al. "Expansion of melanoma-specific cytolytic CD8+ T cell precursors in patients with metastatic melanoma vaccinated with CD34+ progenitor-derived dendritic cells." The Journal of experimental medicine 199.11 (2004): 1503-1511.

Velders, Markwin P., et al. "Identification of peptides for immunotherapy of cancer. It is still worth the effort." Critical Reviews™ in Immunology 18.1-2 (1998).

Valmori, Danila, et al. "Analysis of MAGE-3-specific cytolytic T lymphocytes in human leukocyte antigen-A2 melanoma patients." Cancer research 57.4 (1997): 735-741.